SUPPLEMENTAL INTRAVENOUS FLUIDS AS A TREATMENT MODALITY FOR SEVERE NON-HEMOLYTIC NEONATAL HYPERBILIRUBINEMIA
(2023). SUPPLEMENTAL INTRAVENOUS FLUIDS AS A TREATMENT MODALITY FOR SEVERE NON-HEMOLYTIC NEONATAL HYPERBILIRUBINEMIA. EKB Journal Management System, 26(2), 3342-3354. doi: 10.21608/azjp.2023.297284
. "SUPPLEMENTAL INTRAVENOUS FLUIDS AS A TREATMENT MODALITY FOR SEVERE NON-HEMOLYTIC NEONATAL HYPERBILIRUBINEMIA". EKB Journal Management System, 26, 2, 2023, 3342-3354. doi: 10.21608/azjp.2023.297284
(2023). 'SUPPLEMENTAL INTRAVENOUS FLUIDS AS A TREATMENT MODALITY FOR SEVERE NON-HEMOLYTIC NEONATAL HYPERBILIRUBINEMIA', EKB Journal Management System, 26(2), pp. 3342-3354. doi: 10.21608/azjp.2023.297284
SUPPLEMENTAL INTRAVENOUS FLUIDS AS A TREATMENT MODALITY FOR SEVERE NON-HEMOLYTIC NEONATAL HYPERBILIRUBINEMIA. EKB Journal Management System, 2023; 26(2): 3342-3354. doi: 10.21608/azjp.2023.297284